Interesting: Ebola Evidence
Written by Editor   
Thursday, October 16, 2014 12:04 PM

Among all of the Ebola news that is going on out there here are some excerpts from various articles offering some interesting perspectives.  Among them are "Further supporting this genetic engineering research claim, the U.S. government patented Ebola in 2010 and now claims intellectual property ownership over all Ebola variants. That patent number is CA2741523A1, viewable at this link" which states, among other things

"The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention ("CDC"; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291. ... Samples of the stated Deposit Accession No. 200706291 will be made available to approved facilities for thirty years from the date of deposit, and for the lifetime of the patent issuing from, or claiming priority to this application. ... The invention is related to compositions and methods directed to a novel species of human Ebola (hEbola) virus."

Other interesting comments from the patent include how Ebola was discovered: "The family Filoviridae consists of two genera, ... which have likely evolved from a common ancestor'. The genus Ebolavirus includes four species: Zaire, Sudan, Reston and Cote d'Ivoire (Ivory Coast) ebolaviruses, which have, with the exception of Reston and Cote d'Ivoire ebolaviruses, been associated with large hemorrhagic fever (HF) outbreaks in Africa with high case fatality (53-90%)." 

"Identification of the natural reservoir of ebolaviruses remains somewhat elusive, although recent PCR and antibody data suggest that three species of arboreal fruit bats may be carriers of Zaire ebolavirus. No data has yet been published to suggest reservoirs for the Sudan, Reston and Cote d'Ivoire ebolavirus species. However, a cave-dwelling fruit bat has been recently implicated as a natural host for marburgvirus4' s, supporting the hypothesis that different bat species may be the reservoir hosts for the various filoviruses."  

"Filovirus outbreaks are sporadic, sometimes interspersed by years or even decades of no apparent disease activity. The last new species of ebolavirus was discovered 14 years ago (1994), in Cote d'Ivoire (Ivory Coast), and involved a single non-fatal case, a veterinarian who performed an autopsy on an infected chimpanzee found in the Tai Forest. No further disease reports have been associated with Cote d'Ivoire ebolavirus, in contrast to Zaire and Sudan ebolaviruses which have each caused multiple large outbreaks over the same time period."  

"In late November 2007, HF cases were reported in the townships of ... in ... Western Uganda. The outbreak continued through January 2008, and resulted in approximately 149 cases and 37 deaths. Laboratory investigation of the initial 29 suspect-case blood specimens ... identified this to be an Ebola HF
outbreak associated with a new discovered ebolavirus species. ... This new species is referred to herein as "the Bundibugyo species", abbreviated "EboBun". 

"Accordingly, compositions and methods directed to the new Ebola virus species are described herein ... including related vaccine development, and prevention of hemorrhagic fever in a human population."

"The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. ... the invention provides the isolated EboBun virus deposited with the Centers for Disease Control and Prevention ... on November 26, 2007 and accorded an accession number 200706291...."

"In other aspects, the invention relates to the use of the isolated hEbola virus for diagnostic and therapeutic methods based on EbBun, EboIC, or a combination thereof."

"The invention provides vaccine preparations, comprising the inventive hEbola virus, including recombinant and chimeric forms of the virus, nucleic acid molecules comprised by the virus, or protein subunits of the virus. The invention also provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of the inventive hEbola virus described above, and a pharmaceutically acceptable carrier." 

"The present invention provides pharmaceutical compositions comprising antiviral agents of the present invention and a pharmaceutically acceptable carrier. In a specific embodiment, the antiviral agent of the invention is an antibody that immunospecifically binds hEbola virus or any hEbola epitope. In another specific embodiment, the antiviral agent is a polypeptide or protein of the present invention or nucleic acid molecule of the invention." 
"The invention provides a pharmaceutical composition comprising a prophylactically or therapeutically effective amount of an anti-hEbola EboBun agent and a pharmaceutically acceptable carrier."


 Other interesting statements that have come to light, backed by evidence, include:  "That patent, number CA2741523A1, available here. ... claims U.S. government ownership over all variants of Ebola which share 70% or more of the protein sequences described in the patent: '[CLAIMS] ...a nucleotide sequence of at least 70%-99% identity to the SEQ ID...'  Furthermore, the patent also claims ownership over any and all Ebola viruses which are 'weakened' or 'killed,' meaning the United States government is literally claiming ownership over all Ebola vaccines.'

"What this means, of course, is that the U.S. government can demand royalties on all Ebola vaccines. Even more Orwellian is the fact that the U.S. government can use this patent to halt all other research for treatments or cures for Ebola."

"Do you remember the massive medical controversy over the gene tied to breast cancer in women? One corporation claimed patent ownership over the gene and then they used that patent to shut down all other research, testing or diagnosis of breast cancer related to that gene. ... The controversy went all the way to the U.S. Supreme Court which ultimately ruled that human genes cannot be patented. But the Supreme Court decision actually protected patents on gene sequences for viruses and other pathogens."


Finally, this article highlights some of the same mis-information:

"The public isn't being told the truth about how Ebola spreads and how individuals can help prevent transmission of the disease.  At every level of media and government, protecting the financial interests of drug companies appears to be far more important than protecting public health. So people aren't told the truth about how Ebola spreads and how they can increase their ability to survive ..."

"Here are five of the biggest lies being spread about Ebola:"

 "Lie #1) Ebola won't ever come to the United States.  This lie was shattered just this week when the CDC confirmed Ebola in a hospital patient in Dallas, Texas.

"Lie #2) Ebola is only spread via direct contact with body fluids.  This outrageous medical lie may soon cost the lives of ... innocent people. In truth, Ebola can spread through the air over short distances via aerosols - airborne particles.  Ebola can also spread via contaminated surfaces. When an infected patient makes contact with a surface ... they may leave behind the Ebola virus which survives for many minutes or hours ... depending on environmental conditions. ... Another person who touches the same surface may then become ... infected by simply touching their own eyes, nose or mouth.  The ability of Ebola to spread via contaminated surfaces is why victims in Africa have become infected by riding in taxi cabs."

"Lie #3) Don't worry: Health authorities have everything under control.  The overarching lie about Ebola that's being repeated by the U.S. government is "Don't worry, we have it under control!"  Of course, the fact that an infected Ebola victim just flew right into the country with Ebola, then walked around the city of Dallas for 10 days while carrying Ebola, utterly belies the false promises of health authorities who claim to have things under control."

"The sobering fact of the matter is that despite all the money being spent on 'homeland security,' DHS has no way to stop Ebola from walking right into the USA, including on foot from our wide open southern border."

"Lie #4) The only defense against Ebola is a vaccine or a pharmaceutical drug. ... Instead of urging the public to enhance their immune function and boost their natural defenses against Ebola, everyone is ridiculously told to "wash your hands" and wait around for a drug company to introduce an Ebola vaccine."

"Lie #5) Ebola came out of nowhere and was a random fluke of nature. The modern-day version of Ebola that's so aggressively circulating today may actually be a bioengineered virus, according to one scientist who wrote a front-page story in Liberia's largest newspaper.  Ebola is a genetically modified organism (GMO)," declared Dr. Cyril Broderick, Professor of Plant Pathology, in a front-page story published in the Liberian Observer."